Cargando…

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice

Chronic stress is known to induce not only anxiety and depressive-like phenotypes in mice but also cognitive impairments, for which the action of classical antidepressant compounds remains unsatisfactory. In this context, we investigated the effects of chronic social defeat stress (CSDS) on anxiety-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Vincent, Allaïli, Najib, Euvrard, Marine, Marday, Tevrasamy, Riffaud, Armance, Franc, Bernard, Mocaër, Elisabeth, Gabriel, Cecilia, Fossati, Philippe, Lehericy, Stéphane, Lanfumey, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379201/ https://www.ncbi.nlm.nih.gov/pubmed/28374847 http://dx.doi.org/10.1038/srep45907

Ejemplares similares

Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine
por: Boulle, F, et al.
Publicado: (2014)

Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes
por: Milanese, Marco, et al.
Publicado: (2013)

α(2)- and β(2)-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve
por: M’Dahoma, Saïd, et al.
Publicado: (2018)

Hippocampal Neurogenesis, Depressive Disorders, and Antidepressant Therapy
por: Paizanis, Eleni, et al.
Publicado: (2007)

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT(2C )receptor-dependent pathways
por: Tardito, Daniela, et al.
Publicado: (2010)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers
por: Can, Özgür Devrim, et al.
Publicado: (2018)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Defeat
por: Niburski, Kacper
Publicado: (2023)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

A circuit from dorsal hippocampal CA3 to parvafox nucleus mediates chronic social defeat stress–induced deficits in preference for social novelty
por: Liu, Yang, et al.
Publicado: (2022)

Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling
por: Règue, Mathilde, et al.
Publicado: (2019)

Immune to defeat
por: Reese, Michael L
Publicado: (2013)

The Defeat of the Bill
Publicado: (1894)

Defeat Such Legislation
Publicado: (1901)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Brain histamine and oleoylethanolamide restore behavioral deficits induced by chronic social defeat stress in mice
por: Rani, Barbara, et al.
Publicado: (2021)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
por: Rami, Marouan, et al.
Publicado: (2012)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Wnt defeats death
por: Wells, William A.
Publicado: (2002)

Defeating cancer with antidepressants
por: Lieb, J
Publicado: (2008)

Defeater Goes External
por: Janvid, Mikael
Publicado: (2017)

Osteopathy Bill Defeated
Publicado: (1905)

Hop Bitter Acids Increase Hippocampal Dopaminergic Activity in a Mouse Model of Social Defeat Stress
por: Ano, Yasuhisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_93ee1m72stajm2gplmtohjc0qt